Restart Life Sciences Corp. (CNSX: HEAL)
Health Care · Biotechnology · CA
CA$0.07
-6.67% today · -41.7% 1Y
Restart Life Sciences Corp. (CNSX: HEAL) operates in the Biotechnology industry within the Health Care sector. The company is valued at $3.06M and employs 3 people.
Over the last twelve months the share price has lost 41.7%, trading between 0.07 and 0.14.
Tweenvest scores Restart Life Sciences Corp. across four factors: quality 36/100, value 48/100. Its strongest factor is value.
HEAL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.06M
- Revenue (TTM)
- $327.94K
- P/E
- —
- EPS
- -0.04
- Dividend yield
- —
- Beta (5Y)
- -0.78
- 52-week high
- CA$0.14
- 52-week low
- CA$0.07
- Avg volume (3M)
- —
- Shares outstanding
- 62.51M
- Employees
- 3
- Next earnings
- —
About Restart Life Sciences Corp.
Operating internationally through its various subsidiaries, Restart Life Sciences Corp. functions as a biotechnology firm. Its core endeavors include the creation of natural therapeutic remedies tailored for individuals with autism spectrum disorder, the development of health-promoting foods designed for comprehensive mind and body wellness, and the execution of a psilocybin clinical trial aimed at fragile X syndrome. Founded in 2004 and based in Vancouver, Canada, the company adopted its current name in November 2024, having previously been known as Nova Mentis Life Science Corp.
- ISIN
- CA76134J2065
- Founded
- 2004
- Listed since
- Sep 22, 2006
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| National Graphite Corp.OTCPK: NGRC | $3.41M | $0.02 | +5.24% |
| Chosa Oncology ABNGM: CHOSA | $3.31M | Skr— | — |
| Affymax, Inc.OTCPK: AFFY | $3.10M | $0.04 | +2500.00% |
| Calidi Biotherapeutics, Inc.NYSEAM: CLDI | $3.09M | $0.84 | -18.74% |
| GRI Bio, Inc.NasdaqCM: GRI | $3.02M | $1.38 | -20.69% |
| Eocene Ltd.NasdaqCM: EOCN | $2.97M | $2.85 | -19.49% |
| Aptevo Therapeutics Inc.NasdaqCM: APVO | $2.92M | $1.62 | -9.50% |
| Mustang Bio, Inc.NasdaqCM: MBIO | $2.85M | $0.38 | -5.92% |
Figures last refreshed Oct 18, 2026.